Guided Therapeutics (GTHP) Operating Leases (2019 - 2025)
Guided Therapeutics' (GTHP) quarterly Operating Leases came in at $651000.0 in Q4 2025, up 320.0% year-on-year from $155000.0 in Q4 2024, and up 756.58% quarter-over-quarter from $76000.0 in Q3 2025.
Guided Therapeutics (GTHP) Operating Leases (2019 - 2025) Analysis & Trends
Guided Therapeutics has disclosed Operating Leases across 7 years of filings, most recently posting $651000.0 for Q4 2025.
- Operating Leases for Q4 2025 came in at $651000.0, up 320.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $651000.0 (up 320.0% YoY), and the FY2025 annual result was $651000.0, up 320.0% from the prior year.
- Operating Leases came in at $651000.0 for Q4 2025 at Guided Therapeutics, up from $76000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $651000.0 in Q4 2025 to a low of $377.0 in Q1 2022.
- The 5-year median for Operating Leases is $267000.0 (2022), against an average of $264388.3.
- Across the five-year window, Operating Leases tumbled 99.9% in 2022 and surged 59581.7% in 2023, its largest moves.
- Guided Therapeutics' Operating Leases stood at $325000.0 in 2021, then changed by 0.0% to $325000.0 in 2022, then retreated by 24.31% to $246000.0 in 2023, then sank by 36.99% to $155000.0 in 2024, then jumped by 320.0% to $651000.0 in 2025.
- The last three Operating Leases figures came in at $651000.0 (Q4 2025), $76000.0 (Q3 2025), and $130000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 651,000.00 |
| Sep 30, 2025 | 76,000.00 |
| Mar 31, 2025 | 130,000.00 |
| Dec 31, 2024 | 155,000.00 |
| Sep 30, 2024 | 178,000.00 |
| Jun 30, 2024 | 104,000.00 |
| Mar 31, 2024 | 225,000.00 |
| Dec 31, 2023 | 246,000.00 |
| Sep 30, 2023 | 267,000.00 |
| Jun 30, 2023 | 287,000.00 |
| Mar 31, 2023 | 225,000.00 |
| Dec 31, 2022 | 325,000.00 |
| Sep 30, 2022 | 267,000.00 |
| Jun 30, 2022 | 360,000.00 |
| Mar 31, 2022 | 377.00 |
| Dec 31, 2021 | 325,000.00 |
| Sep 30, 2021 | 407,000.00 |
| Jun 30, 2021 | 419,000.00 |
| Mar 31, 2021 | 376,000.00 |
| Dec 31, 2020 | 392,000.00 |